Humira

2 statements across 1 episodes · 1 bullish · 0 bearish · 1 people on the record · first statement Jan 22, 2024 by Ben Gilbert · said 3 times in 1 episodes since 2024 · across every show →

Mentions by year

brought up most by Ben Gilbert (3)

tap a year for its mentions
0021312024episodesmentions
0112024episodes it came up in
001.50.5312024episodesmentions per episode
2024 3 mentions in 1 episode

every mention, scene by scene, with the transcript →

Everything said about Humira, oldest first

Jan 22, 2024 neutral
Assertion Supported
AbbVie's Humira generated $200 billion across 11 approved indications
“Humira by AbbVie, that generated two hundred billion dollars in lifetime sales since Humira was approved for 11 different indications across this whole spectrum of inflammatory and autoimmune disorders.”
Ben Gilbert Jan 22, 2024 ▶ 3:34:14 Novo Nordisk (Ozempic) · Acquired
Jan 22, 2024 bullish
Prediction Not checkable as stated
GLP-1s could surpass Humira and remain defensible for a decade
“So I think, assuming that Novo stays sort of neck and neck with Eli Lilly as they both keep coming out with better and better versions, that this could be the next Humira, or potentially much bigger than Humira. And I think the defensibility is an open questio…”
Ben Gilbert Jan 22, 2024 ▶ 3:35:25 Novo Nordisk (Ozempic) · Acquired
Made with StarZero

Turn any episode into a week of clips.

This entire site, nearly 80 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.